跳至主要内容
临床试验/NCT06386458
NCT06386458已完成不适用

A Prospective, Multicenter, Randomized Controlled, Non-inferiority Clinical Study Evaluating the Safety and Efficacy of the AThrough Radiofrequency Transseptal Puncture System in Atrial Septal Puncture.

Hangzhou NOYA MedTech Co. Ltm.4 个研究点 分布在 1 个国家目标入组 177 人开始时间: 2022年7月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
177
试验地点
4
主要终点
Transseptal puncture success rate.

研究概览

简要总结

This study is a prospective, multicenter, randomized controlled trial with a non-inferiority design. Participants are patients scheduled for atrial septal puncture. After signing informed consent, subjects will be randomly assigned to either the radiofrequency transseptal puncture system group (referred to as the trial group) or the traditional mechanical transseptal puncture system group (referred to as the control group). All participants will undergo immediate postoperative and discharge clinical follow-ups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient age ≥ 18 years;
  • Subjects scheduled to undergo cardiology interventional treatment via the transseptal puncture route;
  • Subjects have been informed about the nature of the study, understand the purpose of the clinical trial, and voluntarily participate and sign the informed consent form.

排除标准

  • Echocardiogram indicates the presence of intracardiac masses, thrombi, or vegetations; left atrial myxoma;
  • Subjects with an atrial septal defect occluder or atrial septal patch implant;
  • Hemorrhagic disease or coagulopathy; or contraindications to antithrombotic medication treatment;
  • Acute myocardial infarction occurred within the last 4 weeks;
  • End-stage heart failure (ACC/AHA stage D); post-heart transplant; or awaiting heart transplant;
  • Pregnant or breastfeeding women;
  • Acute systemic infection or sepsis;
  • Participation in any drug and/or medical device clinical trial within the last month;
  • Researchers judge the patient's compliance to be poor, unable to complete the study as required; or other situations deemed by the researchers as making the subject unsuitable for participation in the study.

结局指标

主要结局

Transseptal puncture success rate.

时间窗: Intraprocedural assessment

Defined as successfully completing the puncture in the atrial septum and establishing a pathway from the right atrium to the left atrium (with the sheath entering the left atrium) using the transseptal puncture system

次要结局

  • Initial transseptal puncture success rate.(Intraprocedural assessment)
  • Number of attempts needed to successfully complete the transseptal puncture.(Intraprocedural assessment)
  • Time required to successfully complete the transseptal puncture.(Intraprocedural assessment)
  • Ratio of atrial septal puncture failures that cross over to the opposite group.(Intraprocedural assessment)

研究者

发起方
Hangzhou NOYA MedTech Co. Ltm.
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验